GlassScriptPhysician profile
Amanda A Temple
NPI 1952893893
$667.11
in general payments reported to CMS, 2019-2025
16 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $454 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.46 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $107.33 | 2021 | |
| Collegium Pharmaceutical, INC. | $80.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.65 | 2025 | |
| Abbott Laboratories | $53.98 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $44.32 | 2025 | Rexulti |
| Amgen INC. | $41.63 | 2021 | |
| Lundbeck LLC | $35.98 | 2021-2025 | Rexulti |
| Corium, LLC | $28.63 | 2025 | Azstarys |
| Axsome Therapeutics, INC. | $17.85 | 2025 | Auvelity |
| Glaxosmithkline, LLC. | $14.94 | 2025 | Shingrix, Arexvy |
| Scilex Pharmaceuticals INC. | $14.66 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.20 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $13.92 | 2025 | |
| Novartis Pharmaceuticals Corporation | $11.44 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Temple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.